Pharmaceuticals, Biotechnology and Life Sciences
hVIVO has signed a contract with Inhalon Biopharma to assess its inhaled IN-002 antiviral candidate (“IN-002”) using the hVIVO Respiratory Syncytial Virus (RSV) Human Challenge Model.
Affluent Medical, a French medtech company at the forefront of developing advanced implantable devices, has reached a key milestone in its mission to improve men’s healthas by successfully completing the pilot phase of its clinical study for the Artus system, an innovative artificial urinary sphincter (AUS) designed to treat stress urinary incontinence in men.
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global…
Brenntag Pharma on Wednesday announced the expansion of the collaboration with Citribel for the distribution of citric acids and citrates.…
Novadip Biosciences, a clinical stage biotechnology company specializing in regenerative medicine, Tuesday said it has completed the 12-month post-surgical visit…
The global specialist pharmaceutical services company, Clinigen, announced on Monday a strategic partnership with Tepsivo, a pioneering global digital Pharmacovigilance…
AB2 Bio Ltd., a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven…
Moderna has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway…
Medix Biochemica, a global leader in the supply of critical raw materials for the in vitro diagnostics (IVD) industry, announced the acquisition of CANDOR Bioscience GmbH, a Germany-based developer and manufacturer of premium immunoassay solutions.
RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company has made an additional investment in the Series C financing round of Umoja Biopharma (“Umoja”), a clinical-stage biotechnology company aiming to develop in vivo cell therapies that improve the reach, effectiveness, and access of CAR T cell therapies in oncology and autoimmune treatments.